He is a physician-scientist who focused on developing novel immunotherapies primarily for hematologic malignancies as well as some solid tumors. Dr. Al-Atrash also studies antigen presentation/ cross-presentation mechanisms in solid tumors and the value of immune checkpoint blockade in leukemia.